Lenzilumab
Product Specifications
CAS Number
1229575-09-0
Target
C-Fms, SARS-CoV
Related Pathways
Microbiology/Virology, Tyrosine Kinase/Adaptors
Purity
0.989
Bioactivity
Lenzilumab (KB 003) is a humanized granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibody that directly binds to GM-CSF and prevents signaling through its receptor, and can be used to study COVID-19.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1171722-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Cell division protein ZapA (zapA)
Sign In for Pricing
View Details MBS1171722-02 0.1 mg (E-Coli)
Recombinant Escherichia coli Cell division protein ZapA (zapA)
Sign In for Pricing
View Details MBS1171722-03 0.02 mg (Yeast)
Recombinant Escherichia coli Cell division protein ZapA (zapA)
Sign In for Pricing
View Details